Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration in COVID-19 (REALIST-COVID-19): A structured summary of a study protocol for a randomised, controlled trial
Abstract Objectives The primary objective of the study is to assess the safety of a single intravenous infusion of Mesenchymal Stromal Cells (MSCs) in patients with Acute Respiratory Distress Syndrome (ARDS) due to COVID-19. Secondary objectives are to determine the effects of MSCs on important clin...
Main Authors: | Ellen Gorman, Manu Shankar-Hari, Phil Hopkins, William S. Tunnicliffe, Gavin D. Perkins, Jonathan Silversides, Peter McGuigan, Colette Jackson, Roisin Boyle, Jamie McFerran, Cliona McDowell, Christina Campbell, Margaret McFarland, Jon Smythe, Jacqui Thompson, Barry Williams, Gerard Curley, John G. Laffey, Mike Clarke, Cecilia O’Kane, Daniel F. McAuley |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-06-01
|
Series: | Trials |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13063-020-04416-w |
Similar Items
-
Mesenchymal stem cell-based therapy and exosomes in COVID-19: current trends and prospects
by: Mai Abdelgawad, et al.
Published: (2021-08-01) -
Mesenchymal stromal cells as a therapeutic intervention for COVID-19: a living systematic review and meta-analysis protocol
by: Aidan M. Kirkham, et al.
Published: (2021-09-01) -
Challenges for Mesenchymal Stem Cell-Based Therapy for COVID-19
by: Li C, et al.
Published: (2020-09-01) -
Mesenchymal Stromal Cells: Potential Option for COVID-19 Treatment
by: Dragan Primorac, et al.
Published: (2021-09-01) -
A Step Toward Optimizing Regenerative Medicine Principle to Combat COVID-19
by: Shilpa Sharma, et al.
Published: (2021-06-01)